(19)
(11) EP 4 739 293 A2

(12)

(88) Date of publication A3:
13.02.2025

(43) Date of publication:
13.05.2026 Bulletin 2026/20

(21) Application number: 24838953.8

(22) Date of filing: 05.07.2024
(51) International Patent Classification (IPC): 
A61K 31/095(2006.01)
A61P 27/02(2006.01)
C07H 17/00(2006.01)
 A61K 9/00(2006.01)
A61P 29/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 9/0048
(86) International application number:
PCT/IB2024/000365
(87) International publication number:
WO 2025/012700 (16.01.2025 Gazette 2025/03)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 07.07.2023 US 202363525548 P

(71) Applicant: AZURA OPHTHALMICS LTD
6314305 Tel Aviv (IL)

(72) Inventors:
  • RAFAELI, Omer
    6314305 Tel Aviv (IL)
  • ALSTER, Yair
    6314305 Tel Aviv (IL)
  • BOSWORTH, Charles
    6314305 Tel Aviv (IL)
  • GLEESON, Marc
    6314305 Tel Aviv (IL)

(74) Representative: Mewburn Ellis LLP 
Aurora Building Counterslip
Bristol BS1 6BX
Bristol BS1 6BX (GB)

   


(54) COMPOSITIONS AND METHODS FOR THE TREATMENT OF AUTOIMMUNE DISORDERS